FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382517285> ?p ?o ?g. }

• W4382517285 abstract "Abstract Immunomodulation of tumor‐associated macrophages (TAMs) into tumor‐inhibiting M1‐like phenotype is a promising but challenging strategy. Cleverly, tumor cells overexpress CD47, a “don't eat me” signal that ligates with the signal regulatory protein alpha (SIRPα) on macrophages to escape phagocytosis. Thus, effective re‐education of TAMs into the “eat me” type and blocking the CD47‐SIRPα signaling play pivotal roles in tumor immunotherapy. Herein, it is reported that hybrid nanovesicles (hEL‐RS17) derived from extracellular vesicles of M1 macrophages and decorated with RS17 peptide, an antitumor peptide that specifically binds to CD47 on tumor cells and blocks CD47‐SIRP α signaling, can actively target tumor cells and remodel TAM phenotypes. Consequently, more M1‐like TAMs infiltrate into tumor tissue to phagocytize more tumor cells due to CD47 blockade. By further co‐encapsulating chemotherapeutic agent shikonin, photosensitizer IR820, and immunomodulator polymetformin in hEL‐RS17, an enhanced antitumor effect is obtained due to the combinational treatment modality and close synergy among each component. Upon laser irradiation, the designed SPI@hEL‐RS17 nanoparticles exert potent antitumor efficacy against both 4T1 breast tumor and B16F10 melanoma models, which not only suppresses primary tumor growth but also inhibits lung metastasis and prevents tumor recurrence, exhibiting great potential in boosting CD47 blockade‐based antitumor immunotherapy." @default.
• W4382517285 created "2023-06-30" @default.
• W4382517285 creator A5014572828 @default.
• W4382517285 creator A5022358194 @default.
• W4382517285 creator A5034294477 @default.
• W4382517285 creator A5038393165 @default.
• W4382517285 creator A5042937962 @default.
• W4382517285 creator A5043546546 @default.
• W4382517285 creator A5055629026 @default.
• W4382517285 creator A5072655537 @default.
• W4382517285 date "2023-07-13" @default.
• W4382517285 modified "2023-10-14" @default.
• W4382517285 title "Extracellular Vesicles‐Derived Hybrid Nanoplatforms for Amplified CD47 Blockade‐Based Cancer Immunotherapy" @default.
• W4382517285 cites W2064656431 @default.
• W4382517285 cites W2067632426 @default.
• W4382517285 cites W2119437574 @default.
• W4382517285 cites W2148755064 @default.
• W4382517285 cites W2468694810 @default.
• W4382517285 cites W2472500434 @default.
• W4382517285 cites W2585139079 @default.
• W4382517285 cites W2801309958 @default.
• W4382517285 cites W2804669050 @default.
• W4382517285 cites W2915115434 @default.
• W4382517285 cites W2923494869 @default.
• W4382517285 cites W2934022268 @default.
• W4382517285 cites W2969684055 @default.
• W4382517285 cites W2971006194 @default.
• W4382517285 cites W3019038073 @default.
• W4382517285 cites W3104085757 @default.
• W4382517285 cites W3118507078 @default.
• W4382517285 cites W3121844112 @default.
• W4382517285 cites W3129921250 @default.
• W4382517285 cites W3134185379 @default.
• W4382517285 cites W3137357006 @default.
• W4382517285 cites W3155441502 @default.
• W4382517285 cites W3160345061 @default.
• W4382517285 cites W3165495857 @default.
• W4382517285 cites W3194257905 @default.
• W4382517285 cites W3200846644 @default.
• W4382517285 cites W3204088349 @default.
• W4382517285 cites W3216796365 @default.
• W4382517285 cites W4200481514 @default.
• W4382517285 cites W4200483722 @default.
• W4382517285 cites W4205601783 @default.
• W4382517285 cites W4206718515 @default.
• W4382517285 cites W4210920041 @default.
• W4382517285 cites W4213415596 @default.
• W4382517285 cites W4220662296 @default.
• W4382517285 cites W4223509321 @default.
• W4382517285 cites W4282560917 @default.
• W4382517285 cites W4283204981 @default.
• W4382517285 cites W4284879153 @default.
• W4382517285 cites W4287510340 @default.
• W4382517285 cites W4289866450 @default.
• W4382517285 cites W4292092891 @default.
• W4382517285 cites W4298009555 @default.
• W4382517285 cites W4300772736 @default.
• W4382517285 cites W4301392719 @default.
• W4382517285 doi "https://doi.org/10.1002/adma.202303835" @default.
• W4382517285 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37384818" @default.
• W4382517285 hasPublicationYear "2023" @default.
• W4382517285 type Work @default.
• W4382517285 citedByCount "0" @default.
• W4382517285 crossrefType "journal-article" @default.
• W4382517285 hasAuthorship W4382517285A5014572828 @default.
• W4382517285 hasAuthorship W4382517285A5022358194 @default.
• W4382517285 hasAuthorship W4382517285A5034294477 @default.
• W4382517285 hasAuthorship W4382517285A5038393165 @default.
• W4382517285 hasAuthorship W4382517285A5042937962 @default.
• W4382517285 hasAuthorship W4382517285A5043546546 @default.
• W4382517285 hasAuthorship W4382517285A5055629026 @default.
• W4382517285 hasAuthorship W4382517285A5072655537 @default.
• W4382517285 hasConcept C170493617 @default.
• W4382517285 hasConcept C192562407 @default.
• W4382517285 hasConcept C203014093 @default.
• W4382517285 hasConcept C2777658100 @default.
• W4382517285 hasConcept C2777701055 @default.
• W4382517285 hasConcept C2778468042 @default.
• W4382517285 hasConcept C2780104668 @default.
• W4382517285 hasConcept C2780674031 @default.
• W4382517285 hasConcept C502942594 @default.
• W4382517285 hasConcept C55493867 @default.
• W4382517285 hasConcept C86803240 @default.
• W4382517285 hasConcept C8891405 @default.
• W4382517285 hasConceptScore W4382517285C170493617 @default.
• W4382517285 hasConceptScore W4382517285C192562407 @default.
• W4382517285 hasConceptScore W4382517285C203014093 @default.
• W4382517285 hasConceptScore W4382517285C2777658100 @default.
• W4382517285 hasConceptScore W4382517285C2777701055 @default.
• W4382517285 hasConceptScore W4382517285C2778468042 @default.
• W4382517285 hasConceptScore W4382517285C2780104668 @default.
• W4382517285 hasConceptScore W4382517285C2780674031 @default.
• W4382517285 hasConceptScore W4382517285C502942594 @default.
• W4382517285 hasConceptScore W4382517285C55493867 @default.
• W4382517285 hasConceptScore W4382517285C86803240 @default.
• W4382517285 hasConceptScore W4382517285C8891405 @default.
• W4382517285 hasFunder F4320321001 @default.
• W4382517285 hasFunder F4320326182 @default.
• W4382517285 hasIssue "35" @default.
• W4382517285 hasLocation W43825172851 @default.

• next